Oculus Innovative Sciences, Inc.
Oculus Innovative Sciences, Inc., announced its latest developments
Published in Medicine and Law Weekly, July 13th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Oculus Innovative Sciences, Inc.
Report 1: Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) announced the appointment of Jay E. Birnbaum, Ph.D., to its board of directors. Dr. Birnbaum is a pharmacologist and previous to his current role as a consultant to pharmaceutical companies, he served as vice president of global project management at Novartis/Sandoz Pharmaceuticals Corporation, where he had responsibility for strategic planning and development of the company's dermatology...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Cancer Quality of Care
Investigators at Roswell Park Cancer Institute zero in on cancer quality of care - Epidemiology
Scientists at Cornell University describe research in epidemiology - Immunization
Report summarizes immunization study findings from Centers for Disease Control and Prevention - Life Sciences
Findings from University of New Hampshire, Research Center advance knowledge in life sciences - Life Sciences
New life sciences study results from Urban Institute described - Life Sciences
Research from Samford University provides new data on life sciences - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
